SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell shares rose following a strong fiscal second-quarter earnings report that featured record revenue and a massive increase in its AI server backlog, prompting a significant raise to the company's full-year outlook. While the broader market remains cautious, many traders view these results as a strong validation of the ongoing demand for AI infrastructure.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is trending as investors weigh strong fiscal first-quarter earnings and raised guidance against broader market volatility and concerns over cyclical sector rotation. While some traders are focused on the stock's significant price pullback and potential valuation compression, others remain bullish on the long-term hyperscaler and AI connectivity demand, leading to active dip-buying activity.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending as traders analyze the company's fiscal fourth-quarter earnings report, which exceeded revenue and earnings expectations, although the stock faced volatile trading as market participants debated the sustainability of its high valuation multiples. The sentiment remains divided, with some investors focusing on strong growth metrics and guidance, while others express concern over slowing organic growth and an inflated price-to-earnings ratio compared to the broader cybersecurity sector.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB is seeing extreme volatility as traders react to a quarterly earnings beat that failed to overcome concerns regarding a sequential decline in Q3 revenue guidance and a stretched valuation. While some investors view the sell-off as an opportunity, many others are debating whether the company's growth is sufficient to justify its current market cap.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet shares are facing downward pressure as traders debate the company's valuation, capital expenditures, and increased regulatory scrutiny from the FTC. While some investors view the stock as undervalued and point to growing cloud revenue as a long-term catalyst, others express skepticism about AI monetization and broader market headwinds.

GitLab, Inc. engages in the intelligent development, security, and operations (DevSecOps) platform for software innovation. It enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab shares are seeing increased volatility and investor attention as market participants debate the company's valuation and the long-term impact of AI on its core DevSecOps business. While some traders point to the recent $400 million share repurchase program and potential acquisition interest as reasons for optimism, others remain concerned about competitive pressures from AI coding assistants and slowing growth metrics.

Alphabet Inc - Ordinary Shares - Class C

Investors are expressing frustration with the stock's persistent downward trend and lack of support, with many debating the impact of high capital expenditure on earnings and comparing the company's valuation to peers. The conversation remains heavily focused on the stock's failure to maintain momentum despite positive news, such as expanded partnerships and AI product developments.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple shares are experiencing a volatility-driven rally as the market reacts to the formal CEO transition to John Ternus and anticipation surrounding the upcoming iPhone launch event. Traders are debating whether the price strength is a sustainable signal of confidence in the new leadership and product pipeline or a temporary maneuver by algorithms and institutional investors to prop up the broader market.

Fervo Energy Co. operates as a energy company. It builds and operates power facilities in extracting geothermal energy. The company was founded by Jack Norbeck and Timothy Latimer in 2017 and is headquartered in Berkeley, CA.

Fervo Energy Co. - Ordinary Shares - Class A

Fervo Energy Co

Fervo Energy is trending following a significant 396-megawatt power purchase agreement with Google to support AI data center infrastructure. Investors are debating whether this deal represents a fundamental de-risking of the company's geothermal technology or a temporary speculative spike given the long-term project timeline and ongoing capital expenditure requirements.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holding shares are under pressure as traders react to a surprise leadership shake-up, with founders David Allemann and Caspar Coppetti returning as co-CEOs after Martin Hoffmann's departure. While some investors view the transition as a negative source of uncertainty, others interpret the founders' return as a long-term bullish signal for the brand's innovation and execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers

Trump's MFN push expands to nine mid-sized drugmakers, bringing 26 companies under agreements covering 89% of the branded drug market.

$19.6B Infusion In US Plants With Lower Drug Prices: White House’s Deal With Mid-size Drugmakers

Equity

Under the deals, the drug makers would charge Americans no more than the lowest price paid in other rich countries. 

BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines

BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding...

BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the second interim analysis (IA2) of the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA (zanidatamab), in combination with chemotherapy, with and without TEVIMBRA...

Generative "AI" Macro Data Shows U.S. Impacts

There are solid gains to knowledge workers. But smaller ones outside it.

BeOne Medicines Ltd. - Sponsored ADR  (ONC) is a Great Momentum Stock: Should You Buy?

Does BeOne Medicines Ltd. - Sponsored ADR  (ONC) have what it takes to be a top stock pick for momentum investors? Let's find out.

JAZZ, ONC, ZYME Stocks In Focus After FDA Approves Gastroesophageal Cancer Therapy

The FDA approved Jazz Pharma’s Ziihera with chemotherapy, with or without BeOne’s Tevimbra, as an initial treatment for advanced HER2-positive gastroesophageal cancer.


BeOne Medicines Announces U.S. FDA Approval for TEVIMBRA-Based Regimen for First-Line HER2+ GEA

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for TEVIMBRA (tislelizumab) in combination with ZIIHERA (zanidatamab) and...

BeOne Medicines Ltd. - Sponsored ADR  (ONC) Now Trades Above Golden Cross: Time to Buy?

Is it a good or bad thing when a stock experiences a golden cross technical event?

BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries

BeOne Medicines Ltd. (BeOne) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, together with the BeOne Care Foundation, a nonprofit charitable foundation, and The Max Foundation, a leading global health nonprofit organization, today announced the renewal of their partnership...

BeOne Medicines Ltd. raised its 2026 total revenue guidance to $6.6 billion to $6.8 billion, with GAAP operating income of $1.0 billion to $1.1 billion and non-GAAP operating income of $1.7 billion to $1.8 billion.

BeOne Medicines Ltd. experienced increased operating expenses during the second quarter, while facing structural risks related to third-party dependencies, regulatory uncertainty, and the timing of potential future tax benefits.

BeOne Medicines Ltd. delivered strong second-quarter revenue growth driven by BRUKINSA, while simultaneously expanding its manufacturing infrastructure and research capabilities to support its long-term global oncology growth strategy.

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

BeOne Medicines Ltd - ADR

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ONC BeOne Medicines Ltd - ADR

Fundamentals

Latest ONC News